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Assessment of vitamin D, exercise and lipid profile associated with excessive daytime 
sleepiness in school children 
 
Excessive daytime sleepiness (EDS) can adversely impact health-related quality of life, particularly in 
school-age children, where learning and development can be affected. Identifying EDS is important to 
determine any association with another disorder and to maximise the health and wellbeing of such 
children. EDS has been associated with low vitamin D levels and obesity, which may be antecedents 
or consequences to EDS. Sung et al (2021) set out to identify and rank factors associated with EDS in 
children aged 10-12. This study recruited 618 children, and the Paediatric Daytime Sleepiness Scale 
(PDSS) (Drake et al, 2003) was used to determine EDS. A questionnaire was used to assess lifestyle 
and environmental factors, alongside blood sampling, acoustic rhinometry, sexual maturity rating 
(SMR) (Euling et al, 2008) and the Total Five Symptom Score for rhinitis severity (Lee et al, 2019). 
Some 111 children had EDS (507 controls), with no significant difference in age, sex, BMI score, 
weight status and presence of allergic disease. Those with higher PDSS scores fell into the EDS 
group (as would be expected), and children with low HDL-C levels had an increased risk of EDS. Key 
findings from the study were that low levels of circulating vitamin D3 (25(OH)D3), lack of exercise and 
high BMI were highest ranked factors contributing to EDS. These results are important in that they 
highlight the need for optimal vitamin D3, the need for regular exercise and healthy diet/weight 
management to minimise EDS and maximise health-related quality of life. Such results can influence 
health education and promotion strategies, and the study merits repeating in other cultures to 
determine how generalisable the results are.  
 
Sung M, Rhie S, Kim JH et al. Assessment of vitamin D, exercise, and lipid profile associated with 
excessive daytime sleepiness in school children. Sleep Medicine. 2021;77:51—57. 
https://doi.org/10.1016/j.sleep.2020.11.017 
 
Activating autoantibodies against G protein-coupled receptors in narcolepsy type 1 
 
Narcolepsy, a rare neurological disorder that includes severe daytime sleepiness, nocturnal sleep 
disturbance, sleep-related hallucinations and cataplexy. Narcolepsy is classified into two types: 
 
• Narcolepsy type 1 (NT1): this is characterised by cataplexy, which is associated with an 
autoimmune destruction of hypothalamic neurons that produce neuropeptides called orexins 
or hypocretins. These neuropeptides are involved in the neurological control of wakefulness 
and rapid eye movement (REM) sleep. The have roles in parasympathetic and sympathetic 
nervous system regulation and the modulation of pain 
• Narcolepsy type 2 (NT2): this does not feature cataplexy (i.e. termed Narcolepsy without 
cataplexy in many clinical settings), and the link with hypocretins is less clear, with causes 
largely unknown. 
 
Autoantibodies are key molecules involved in autoimmune disease, whereby they target and react 
with a person’s own healthy cells. G protein-coupled receptors (GPCRs) are cell surface receptors 
that activate different signalling pathways in response to a variety of factors. If autoantibodies target 
these receptors, they can activate or inhibit this signalling process, disrupting cell homeostasis. 
Orjatsalo et al (2021) tested the serum of 10 people with NT1 for autoantibodies for these receptors, 
with all people having serum M2 receptor autoantibodies, 90% having serum nociceptor 
autoantibodies and 50% having serum β2 adrenergic receptor autoantibodies. While the sample size 
is low and a much larger study is needed to explore this finding further, it indicates the presence of a 
variety of GPCR-targeted autoantibodies that may be associated with the autonomic occurrences in 
NT1 or be secondary to the destruction of the hypocretin pathways. These autoantibodies may be the 
key to prevention or further treatment of NT1. This study highlights the need to investigate these 
antibodies in a larger study, in order to determine the wider significance of these important and novel 
findings.  
 
Orjatsalo M, Partinen E, Wallukat G et al. Activating autoantibodies against G protein-coupled 
receptors in narcolepsy type 1. Sleep Medicine. 2021;77; 82—87. 
https://doi.org/10.1016/j.sleep.2020.11.038 
 
The epidemiology of traumatic brain injury in children of 15 years and younger in south-
eastern Norway 
 
In the pursuit of preventing traumatic brain injury, it is paramount to understand the factors involved in 
order for targeted interventions to be successful in reducing incidence and subsequent mortality and 
morbidity. Dahl et al (2021) undertook a retrospective study on data from 176 children (via a trauma 
registry in Norway) with a paediatric traumatic brain injury (pTBI) to describe the incidence and injury 
characteristics of all severities of pTBI over a 2-year period. They also explored the effect of age on 
injury mechanism and extent of injury. The Glasgow Coma Scale, including the paediatric version, 
was used to classify the degree of injury, alongside other data (age, location of injury, injury 
mechanism). It was demonstrated that boy:girl incidence ratio was 1.9:1, and the leading cause of 
pTBI was falls (49%); 31% were as a result of transportation accidents, usually involving a bicycle. 
Blunt head trauma was the primary mechanism of injury. Mean length of stay was 5.8 days. Analysis 
of the data showed that, while incidence of pTBI was low compared to other regions, many of the 
incidents were preventable. This is particularly the case in children aged 7 years of age and younger, 
who appeared to sustain more severe injuries. There is potential for road safety interventions and 
those targeting parents of children just beginning to walk. The study noted that individualised follow-
up for all pTBI cases is advisable, particularly in light of neurorehabilitation services for children being 
considered by the researchers as less developed than that of their adult counterparts. The study 
advocates for further research in this area, to uncover the rehabilitation needs of these children and 
their parents and target those aspects not yet addressed by rehabilitation services.  
 
Dahl HM, Andeli N, Løvstad M et al. Epidemiology of traumatic brain injury in children 15 years and 
younger in South-Eastern Norway in 2015–16. Implications for prevention and follow-up needs. Eur J 
Paediatr Neurol. 2020;31:70—77. https://doi.org/10.1016/j.ejpn.2021.02.002 
 
Assessing the efficacy of mild traumatic brain injury management 
 
In a climate of increased pressures on healthcare resources, decisions around follow-up care need to 
be embedded in evidence and in the best interests of patients. Weber et al (2021) focused their study 
on routine follow-up of those with mild traumatic brain injury (mTBI) to determine how necessary and 
effective the use of follow-up head computed tomography (CT) scans are in low-risk traumatic brain 
injury. The retrospective study included 531 patients, of which 119 met the inclusion criteria, which 
included specific criteria of what was deemed an mTBI (no patient had neurosurgical intervention). 
Medical records were reviewed by two independent observers. Descriptive statistics were used to 
calculate means and the odds of having a repeat head CT scan when transferred from an outlying 
facility compared to direct admission to a level 1 trauma centre. Results revealed that those 
transferred to the trauma centre were significantly more likely to have a repeat head CT scan 
compared to those directly admitted. This may have been due to some level of deterioration that 
prompted the transfers, leading to a repeat scan. Some 74% of study patients had at least one repeat 
head CT scan; a low percentage had asymptomatic intracranial haemorrhage expansion or non-focal 
neurological decline, none of which lead to a neurosurgical intervention. Two patients in the study 
were readmitted due to seizures; their head CT scan showed no neurological decline, but rather an 
improved radiological presentation. The researchers concluded that repeat head CT scans in these 
two patients would not have prevented the onset of seizures. Recommendations from the study 
include close monitoring of patients with mTBI through neurological assessment to identify and 
respond to subtle neurological changes, and a low threshold for repeat head CT scan. The 
researchers highlight that, in the presence of neurological deterioration, a repeat head CT scan 
increases the likelihood of neurosurgical intervention by five times in comparison to a routine follow-
up scan (where the neurological presentation does not necessarily prompt the decision to scan, but 
routine does).  
 
Weber M, Nie JZ, Espinosa JA et al. Assessing the efficacy of mild traumatic brain injury 
management. Clinical Neurology and Neurosurgery. 2021;202; 106518. 
 
The return to driving following moderate to severe traumatic brain injury 
 
For those who experience a moderate to severe traumatic brain injury (TBI), it can lead to a 
temporary or permanent period of not being able, or permitted to, drive a car. Driving has an important 
role to play in health-related quality of life, as it is associated with access to employment, social 
integration and meeting a variety of important personal needs. Therefore, a return to driving is often a 
priority for those recovering from a TBI, with varying degrees of success depending on the severity of 
injury. Novack et al (2021) highlight that 40—70% of people return to driving following a TBI, but that 
there is a gap in evidence relating to the timing and other factors. The researchers adopted a follow-
up protocol with eight study sites that involved 618 participants to gather additional data on timing of 
return to driving and the effects of age. Comparisons were made to non-injured drivers. Follow-up 
was initially by telephone, with a subsequent invitation to participate in a survey. Results showed that 
the rate of return to driving was greatest in the first 2 years after injury, reaching 62% at that point, 
with rate of return slowing after that period. Some 78% had returned to driving by 30 years after the 
injury. Of those involved in the study that remained active drivers, 42% reported returning to driving 
within 6 months after injury (n=456) and 93% were driving within 2 years (n=423). Results did not 
differ with age of injury or follow-up, or by gender or location. This study had a large sample and 
diverse spread in comparison with previous studies, demonstrating that more people return to driving 
than previously estimated. When those participants who resumed driving and then stopped are 
eliminated, the present study’s findings are more consistent with others (67% active drivers). 
Uniquely, this study identified that employment, family income, ethnic identity, seizure activity and 
location were significant factors associated with return to driving; return to driving over time is more 
influenced by social and demographic characteristics than injury severity. For example, living in a 
remote area may necessitate returning to driving in comparison to living in an urban area with other 
transport options. Returning to employment also often necessitates driving, with income also required 
to afford the costs associated with driving. With driving linked to improved health-related quality of life, 
provision for timely access to driver assessment and training, regardless of income, employment 
status, and ethnic identity, is necessary for equality of provision and opportunity.  
 
Novack TA, Zhang Y, Kennedy R et al. Return to Driving Following Moderate-to-Severe Traumatic 









Drake C, Nickel C, Burduvali E et al. The paediatric daytime sleepiness scale (PDSS): sleep habits 
and school outcomes in middle-school children. Sleep. 2003;26(4):455—458. 
https://doi.org/10.1093/sleep/26.4.455 
 
Euling SY, Herman-Giddens ME, Lee PA et al. Examination of US Puberty-Timing Data from 1940 to 
1994 for Secular Trends: Panel Findings. Pediatrics. 2008;121(suppl 3):S172—S191. 
https://doi.org/10.1542/peds.2007-1813D  
 
Lee S, Koh HY, Yon DK et al. Association of sensitization to different aeroallergens with airway 
function and nasal patency in urban children. Allergy Asthma Immunol Res. 2019;11(4):572—582. 
https://doi.org/10.4168/aair.2019.11.4.572 
 
 
 
